RxDoctor Payments Data

Lori Cannady

Adult Health · Akron, OHNPI 1427306109

Payments from drug & device makers

$735in general payments, 2019–2025

Across 40 payments — averaging $18.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$169
  • E.r. Squibb & Sons, L.L.C.$116
  • AstraZeneca$62
  • Amgen$61
  • Merck$59
  • Lexicon Pharmaceuticals, Inc.$55
  • plus $213 from 7 others

What the payments were for

  • Food & beverage$735100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$735 in reported general payments places this provider in the 65th percentile of 1,184 adult health providers in Ohio.

See all adult health providers in Ohio

Medicare billing

Part B allowed, 2024
$26,107
Medicare patients
188
Services billed
305

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VyndamaxTafamidis21$460,388
EliquisApixaban291$373,046
EntrestoSacubitril/Valsartan108$132,794
XareltoRivaroxaban52$74,584
Repatha SureclickEvolocumab40$57,975
FarxigaDapagliflozin Propanediol38$56,769
JardianceEmpagliflozin27$37,338
Repatha SyringeEvolocumab16$19,492
BrilintaTicagrelor21$18,392
Dofetilide15$3,514
Metoprolol Succinate244$2,630
Atorvastatin Calcium200$1,882
ClopidogrelClopidogrel Bisulfate88$870
Colchicine11$865
Isosorbide Dinitrate16$854

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerVyndamax, Eliquis$32$833,434312 claims
NovartisEntresto$169$132,794108 claims
AstraZenecaFarxiga, Brilinta$62$75,16159 claims
Johnson & JohnsonXarelto$12$74,58452 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,184 adult health providers in Ohio.

Other adult health in Akron

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →